Literature DB >> 569782

Muscle wasting and carbohydrate homeostasis in Duchenne muscular dystrophy.

M W Haymond, K E Strobel, D C DeVivo.   

Abstract

Carbohydrate homeostasis was evaluated in nine patients with Duchenne muscular dystrophy (DMD), and in six age-matched normal boys. Mild carbohydrate intolerance was observed in the DMD patients during an oral glucose tolerance test. Only minor differences were observed between the DMD patients and the normal subjects during an oral glucose tolerance test. Only minor differnences were observed between the DMD patients and the normal subjects during a 30-hour period of caloric deprivation. Despite obvious muscle wasting and significant hypoalaninemia, the DMD group was resistant to fasting hypoglycemia. Plasma glutamine concentrations were the same in both groups under all study conditions. Dueterium-labeled glucose and alanine flux studies documented normal glucose inflow and outflow rates and decreased alanine inflow and outflow rates in the DMD group. The 40 percent reduction in alanine turnover, however, was less than expected for a group of patients with an estimated 67 percent reduction in muscle mass. These observations suggest that there may be accelerated protein degradation in the muscles of DMD patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 569782     DOI: 10.1212/wnl.28.12.1224

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Myopathy with abnormal mitochondria, transient low electron transport capacity in the respiratory chain, and absence of energy transduction at sites 1 and 2 in vitro.

Authors:  U Trockel; H R Scholte; K V Toyka; H F Busch; I E Luyt-Houwen; J A Berden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-06       Impact factor: 10.154

2.  Components of energy expenditure in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  A Mokhtarian; A Decrouy; A Chinet; P C Even
Journal:  Pflugers Arch       Date:  1996-02       Impact factor: 3.657

3.  Hypoglycemia in patients with congenital muscle disease.

Authors:  Leslie H Hayes; Pomi Yun; Payam Mohassel; Gina Norato; Sandra Donkervoort; Meganne E Leach; Rachel Alvarez; Anne Rutkowski; Natalie D Shaw; A Reghan Foley; Carsten G Bönnemann
Journal:  BMC Pediatr       Date:  2020-02-06       Impact factor: 2.125

Review 4.  Metabolic Dysfunction in Spinal Muscular Atrophy.

Authors:  Marc-Olivier Deguise; Lucia Chehade; Rashmi Kothary
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.